ofloxacin has been researched along with Dyspepsia in 4 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Dyspepsia: Impaired digestion, especially after eating.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of the present study was to assess the efficacy of rifaximin, a poorly absorbed antibiotic, for H." | 2.72 | Rifaximin-based regimens for eradication of Helicobacter pylori: a pilot study. ( Cammarota, G; Candelli, M; Cazzato, A; Finizio, R; Gabrielli, M; Gasbarrini, A; Gasbarrini, G; Lauritano, EC; Nista, EC; Ojetti, V; Santoro, M; Zocco, MA, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erçin, CN | 1 |
| Uygun, A | 1 |
| Toros, AB | 1 |
| Kantarcioğlu, M | 1 |
| Kilciler, G | 1 |
| Polat, Z | 1 |
| Bağci, S | 1 |
| Güzelbulut, F | 1 |
| Sezikli, M | 1 |
| Akkan Çetinkaya, Z | 1 |
| Erhan Altunöz, M | 1 |
| Günes, P | 1 |
| Düzgün, S | 1 |
| Ovünç Kurdas, O | 1 |
| McNulty, CA | 1 |
| Lasseter, G | 1 |
| Shaw, I | 1 |
| Nichols, T | 1 |
| D'Arcy, S | 1 |
| Lawson, AJ | 1 |
| Glocker, E | 1 |
| Gasbarrini, A | 1 |
| Lauritano, EC | 1 |
| Nista, EC | 1 |
| Candelli, M | 1 |
| Gabrielli, M | 1 |
| Santoro, M | 1 |
| Zocco, MA | 1 |
| Cazzato, A | 1 |
| Finizio, R | 1 |
| Ojetti, V | 1 |
| Cammarota, G | 1 |
| Gasbarrini, G | 1 |
2 trials available for ofloxacin and Dyspepsia
| Article | Year |
|---|---|
Comparison of 7- and 14-day first-line therapies including levofloxacin in patients with Helicobacter pylori positive non-ulcer dyspepsia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective A | 2010 |
Rifaximin-based regimens for eradication of Helicobacter pylori: a pilot study.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia | 2006 |
2 other studies available for ofloxacin and Dyspepsia
| Article | Year |
|---|---|
Application of levofloxacine in the second phase of sequential therapy regimen for Helicobacter pylori eradication: is it a good choice?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agent | 2011 |
Is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered?
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Dyspepsia; Endoscopy; England; Fe | 2012 |